|
Jan. 11, 2019 |
|
|
Mar. 16, 2022 |
|
|
jRCT1080224514 |
- |
|
- |
|
Nov. 30, 2020 |
|
No |
|
| version: date: |
Sanofi K.K. |
||
Tokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo 163-1488, Japan |
||
Sanofi K.K. |
||
Tokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo 163-1488, Japan |
||
completed |
April. 26, 2019 |
||
| 150 | ||
Observational |
||
- |
||
treatment purpose |
||
N/A |
||
- |
||
- |
||
| 12age old over | ||
| No limit | ||
Both |
||
- |
||
investigational material(s) |
||
other |
||
other |
||
| Sanofi K.K. | |
| - |
| - | |
| - |
| - | |
| - | |
| JapicCTI-194579 | |
| Japan/Asia except Japan/North America/South America/Europe/Oceania |